References in periodicals archive ?
In both clinical and laboratory studies, Product R has also shown promise for the treatment of viral infections such as AIDS and human papilloma virus (HPV), and autoimmune diseases like rheumatoid arthritis.
The human papilloma virus ( HPV ) can be a leading cause of cervical cancer in women.
Based on our observations and the published data, it appears that these cases may not be associated with the human papilloma virus.
Human papilloma virus is a sexually transmitted virus that causes 99% of invasive cervical cancer.
s new vaccine that protects against four strains of human papilloma virus (HPV) -- specifically those that are known to cause cervical cancer.
Testing for Human Papilloma Virus (HPV), also known as genital warts, is a precursor to cervical cancer.
New research shows that the human papilloma virus which causes cervical cancer is present in most tongue tumours.
The test for Human Papilloma Virus (HPV) revealed 97% of significant cell abnormalities compared with 76% for a smear.
1 issue of the Journal of the National Cancer Institute, women with negative Pap and human papilloma virus (HPV) tests are at very low risk for developing cervical cancer for several years.
Diaz speculates that the chemokine receptor plays a role in the immune response to wart-causing human papilloma virus.
The present Competitive Intelligence Report about HPV Vaccines provides a competitor evaluation in the field of investigational vaccines against infection with the human papilloma virus (HPV) for prophylaxis of genital and anal warts and of cervical precancer as of May 2010.
The chlamydia and gonorrhea assays and a previously approved assay for human papilloma virus can be used to test one patient specimen, according to Digene.

Full browser ?